On September 25, 2015, an objection to the motion for authority to assume and/or assign agreements was filed in the bankruptcy case of Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) and its affiliates.
The filing was assigned docket number 174 and is described on the court’s official docket as follows:
Objection of Susquehanna Commercial Finance, Inc. to Second Notice of Assumption and Assignment of Certain Executory Contracts and Unexpired Leases Pursuant to the Sale of Substantially all of the Debtor’s Assets (related document(s)) Filed by Susquehanna Commercial Finance, Inc. (Attachments: # (1) Certificate of Service) (Tacconelli, Theodore)
Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on August 9, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 15-11663. The bankruptcy case is currently assigned to United States Bankruptcy Judge Laurie Selber Silverstein. The law firm of Pachulski Stang Ziehl & Jones LLP is acting as lead bankruptcy counsel to Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) in the bankruptcy case.